Diabetes Mellitus, Type 2 Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for diabetes mellitus, type 2 in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Thomas Jefferson University, Philadelphia, Pennsylvania
    Locations
    1143 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT07064473 on ClinicalTrials.gov

  2. A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

    The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes lower their blood sugar and body weight. The study has 2 parts: in the first part participant will get either CagriSema or placebo, and in the second par…

    Stage
    Phase 3
    Ages
    10 to 18
    Site
    Children's Hosptl Philadelphia, Philadelphia, Pennsylvania
    Locations
    58 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07282613 on ClinicalTrials.gov

  3. Transformative Research in Diabetic Nephropathy 2.0

    The goal of this observational study is to learn more about kidney health in adults with diabetic kidney disease and other groups. Researchers will study kidney tissue and other samples. They want to learn how sodium-glucose cotransporter-2 (SGLT2) inhibitors, a type of diabetes medicine, may affec…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Penn Presbyterian Medical Center, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT07444203 on ClinicalTrials.gov

  4. Phenotyping Genetic Risk for Type 2 Diabetes

    This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

    Stage
    Not phased
    Ages
    10 to 70
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    2 in total
    Run by
    University of Pennsylvania

    See if you can join NCT04024631 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.